List Of Publications


  1. MS-275, A Class 1 Histone Deacetylase Inhibitor Augments Glucagon-Like Peptide 1 Receptor Agonism to Improve Glycemic Control and Reduce Obesity in Diet-Induced Obese Mice. Shilpak Bele1,2, Shravan Babu Girada1, Aramita Ray1, Abhishek Gupta6, Srinivas Oruganti1, Phanithi Prakash Babu 3, Rahul SR Raylla3, Shashi Vardhan Kalivendi4, Ahamed Ibrahim5, Vishwajeet Puri6, Venkateswar Addala7, Madhumohan R. Katika8, Richard DiMarchi9, Prasenjit Mitra1,1eLife 2020;9:e522122020;9; e52212 DOI: 10.7554/eLife.52212
  2. Inhibiting fusion with cellular membrane system: therapeutic options to prevent severe acute respiratory syndrome coronavirus-2 infection. Prasenjit Mitra. American Journal of Physiology-Cell Physiology 319 (3), C500-C509. Aug 20th, 2020. DOI: 10.1152/ajpcell.00260.2020.
  3. M. Rajadurai. Sustained Release Compositions. Application Number 202041020828, filed in India on May 18, 2020
  4. G. S. Reddy, K. A. Hossain, J. S. Kumar, B. Thirupataiah, R. K. Edwin, V. B. Giliyaru, R. C. Hariharapura, G. G. Shenoy, P. Misra, M. Pal, Novel isatin-indole derivatives as potential inhibitors of chorismate mutase (CM): their synthesis along with unexpected formation of 2-indolylmethylamino benzoate ester under Pd-Cu catalysis. RSC Advances 2020, 10, 289, doi: 10.1039/c9ra09236f
  5. B. Thirupataiah, G. S. Reddy, S. S. Ghule, J. S. Kumar, G. Mounika, K. A. Hossain, J. Mudgal, J. E. Mathew, G. G. Shenoy, K. V. L. Parsa, M. Pal, Synthesis of 11,12-dihydro benzo[c]phenanthridines via a Pd-catalyzed unusual construction of isocoumarin ring / FeCl3-mediated intramolecular arene-allyl cyclization: first identification of a benzo[c]phenanthridine based PDE4 inhibitor. Bioorg. Chem. 2020, 97, 103691
  6. J. S. Kumar, B. Thirupataiah, R. Medishetti, A. Ray, S. D. Bele, K. A. Hossain, G. S. Reddy, R. K. Edwin, A. Joseph, N. Kumar, G. G. Shenoy, C. M. Rao, M. Pal, Rosuvastatin based novel 3-substituted isocoumarins / 3-alkylidenephthalides: Ultrasound assisted synthesis and identification of new anticancer agents. European Journal of Medicinal Chemistry 2020, 201, 112335;
  7. Medishetti R, Rani R, Kavati S, Mahilkar A, Akella V, Saxena U, Kulkarni P*, Sevilimedu A*. A DNAzyme based knockdown model for Fragile-X syndrome in zebrafish reveals a critical window for therapeutic intervention. J Pharmacol Toxicol Methods. 2020 Jan – Feb; 101:106656. doi: 10.1016/j.vascn.2019.106656. PMCID: 31734279
  8. Kulkarni P, Sevilimedu A. The Known Unknowns: Missing Pieces in in vivo Models of Fragile X Syndrome. J Rare Dis Res Treat. (2020) 5(1): 1-9

Complete year-wise list